Strain Information | |
---|---|
Image | |
BRC No. | RBRC04892 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | B6(Cg)-Aicda<tm2.1Hon> |
Former Common name | B6-AID KI/G23S |
H-2 Haplotype | |
ES Cell line | Bruce 4 [B6.Cg-Thy1<a>] |
Background strain | |
Appearance | |
Strain development | Developed by Min Wei and Tasuku Honjo, Gradutate School of Medicine, Kyoto University in 2007. |
Strain description | |
Colony maintenance | Heterozygote x Wild-type [C57BL/6J(Crlj)] |
References | Separate domains of AID are required for somatic hypermutation and class-switch recombination. Shinkura R, Ito S, Begum N A, Nagaoka H, Muramatsu M, Kinoshita K, Sakakibara Y, Hijikata H, Honjo T Nat. Immunol., 5, 707-712 (2004). 15195091Mice carrying a knock-in mutation of Aicda resulting in a defect in somatic hypermutation have impaired gut homeostasis and compromised mucosal defense. Wei M, Shinkura R, Doi Y, Maruya M, Fagarasan S, Honjo T Nat. Immunol., 12, 264-270 (2011). 21258321 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Aicda MGI:1342279 | activation-induced cytidine deaminase | 6 | Aicda<tm2.1Hon> MGI:4942397 | targeted mutation 2, Tasuku Honjo | |||
loxP | phage P1 loxP | 6 | loxP |
Phenotype | |
---|---|
Phenotype annotation from literatures by Mammalian phenotype ontology | more 2 phenotypes |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | Phage P1 loxP site, mouse Aicda (G23S) genomic DNA |
Research application | Cre/loxP system |
Specific Term and Conditions | 1) The RECIPIENT shall use the BIOLOGICAL RESOURCE only for academic research for the purpose of publishing the research results. 2) In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR and a citation of the following literature(s) designated by the DEPOSITOR are requested. Nat. Immunol., 12, 264-270 (2011). 3) RECIPIENT shall notify the PROVIDER upon filing a patent application claiming modification of the BIOLOGICAL RESOURCE or method(s) of manufacture or use(s) of the BIOLOGICAL RESOURCE. |
Depositor | Tasuku Honjo (Kyoto University) |
Strain Status | ![]() ![]() |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved sperm (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |